The Year in Biotech and What’s Ahead for 2026
Biotech stocks staged a dramatic turnaround in 2025, with the XBI well outpacing the S&P 500 despite concerns over leadership changes at the U.S. ...
Developing an Alternative to Opioids for Post-Surgical Pain
The approach to post-surgical pain relief has relied on short-duration treatments and notably opioids. That’s led to the associated risks of dependenc...
Leveraging the Power of Vocal Biomarkers
Physicians can learn a lot from talking to patients, and not just from the words they say, but from millions of data points from acoustic features of ...
Determining the Cause and Severity of Sepsis with a Point-of-Care Test
Sepsis remains one of medicine’s most intractable and costly problems, arising when an infection triggers a runaway immune response that damages organ...
Separating Signal from Noise in Regenerative Therapies
Rion is developing platelet-derived exosome therapeutics as off-the-shelf, room-temperature-stable alternatives to traditional cell therapies. The com...
Rewriting Drug Discovery with an AI-Multi-Omics Approach
The genomics revolution promised to unravel diseases and lead to treatments that addressed their root causes. In reality, says Mo Jain, your zip code ...
Overcoming Chemoresistance and Activating the Immune System in Difficult-to-Treat Cancers
The enzyme GSK3β, in healthy cells, is involved in glucose metabolism. In cancer cells, though, it serves as a master regulator of tumor growth, progr...
A Hub-and-Spoke Ophthalmology Company with an Eye for Innovation
Hub-and-spoke business models—the use of a central core of business functions with pipeline assets spun out into subsidiary companies—have gained trac...
An AI Collaborative that Welcomes All into the Fold
OpenFold, an open-source, collaborative initiative founded in 2022 to address the challenges of protein structure prediction and design using artifici...
Hitting the Reset Button on Cellular Aging
Transcription factors control the genetic programs that maintain cellular balance, but while they have been seen as compelling targets for aging-relat...